Geneva – Through the Unitaid-funded Optimal ARV project, CHAI’s HIV Access Program recently launched an online HIV New Product Introduction Toolkit and an accompanying HIV New Product Introduction Guide to provide partners and Ministries of Health with the tools and resources needed to introduce and scale up new optimal antiretrovirals (ARV) in-country.

These tools were developed in line with the World Health Organization’s 2016 guidelines, which include a number of ARV medications that are more effective, tolerable and affordable than standard regimens. They are expected to help accelerate access to the best available treatment options for those who need them most and support significant scale-up of treatment, thereby saving money, and achieving public health goals.

The toolkit and guide include a wide range of information, tools, and resources about introducing new products. Topics include product adoption, forecasting, procurement, facility phase-in, and supply planning and monitoring. Together, these guides provide a comprehensive overview of key considerations for adopting and rolling out new HIV products. They also provide resources to support implementation.

The toolkit and guide are made available at a pivotal time for introducing optimal ARVs to millions of patients around the world.

Accelerating access to new, optimal, and cost-effective antiretroviral drugs is central to Unitaid’s strategy in reaching the fast-track “90-90-90” targets by 2020.

Find out more:

HIV New Product Introduction Toolkit